Literature DB >> 25190700

Genetic kidney cancer syndromes.

Thai H Ho1, Eric Jonasch1.   

Abstract

Hereditary forms of renal cell carcinoma (RCC) have yielded clues regarding the molecular pathogenesis of sporadic RCC. The discovery of germline mutations in chromatin-modulating enzymes also defined a new hereditary RCC syndrome. Although histologically distinct RCC subtypes exist, emerging themes shared between hereditary and sporadic RCC include dysregulation of the von Hippel-Lindau tumor suppressor protein/hypoxia inducible factor axis, defective ciliogenesis, and aberrant tumor metabolism. This article describes the most common hereditary RCC syndromes and associated extrarenal manifestations. Recent evidence supports developing screening guidelines for early-onset RCC to identify persons with germline mutations in the absence of secondary clinical manifestations.
Copyright © 2014 by the National Comprehensive Cancer Network.

Entities:  

Mesh:

Year:  2014        PMID: 25190700     DOI: 10.6004/jnccn.2014.0129

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  10 in total

1.  Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial.

Authors:  Eric Jonasch; Ian E McCutcheon; Dan S Gombos; Kamran Ahrar; Nancy D Perrier; Diane Liu; Christine C Robichaux; Mercedes F Villarreal; Justin A Weldon; Ashley H Woodson; Patrick G Pilie; Gregory N Fuller; Steven G Waguespack; Surena F Matin
Journal:  Lancet Oncol       Date:  2018-09-17       Impact factor: 41.316

2.  Renal cell carcinoma risk is associated with the interactions of APOE, VHL and MTHFR gene polymorphisms.

Authors:  Cai Lv; Zhiming Bai; Zhenxiang Liu; Pengcheng Luo; Jie Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 3.  Hereditary Renal Tumor Syndromes: Update on Diagnosis and Management.

Authors:  Sonia Gaur; Baris Turkbey; Peter Choyke
Journal:  Semin Ultrasound CT MR       Date:  2016-10-14       Impact factor: 1.875

4.  The kidney cancer research priority-setting partnership: Identifying the top 10 research priorities as defined by patients, caregivers, and expert clinicians.

Authors:  Jennifer Jones; Jaimin Bhatt; Jonathan Avery; Andreas Laupacis; Katherine Cowan; Naveen Basappa; Joan Basiuk; Christina Canil; Sohaib Al-Asaaed; Daniel Heng; Lori Wood; Dawn Stacey; Christian Kollmannsberger; Michael A S Jewett
Journal:  Can Urol Assoc J       Date:  2017-11-01       Impact factor: 1.862

5.  Pilot study of dovitinib in patients with von Hippel-Lindau disease.

Authors:  Patrick Pilié; Elshad Hasanov; Surena F Matin; Ashley H Henriksen Woodson; Valerie D Marcott; Shelly Bird; Rebecca S Slack; Gregory N Fuller; Ian E McCutcheon; Eric Jonasch
Journal:  Oncotarget       Date:  2018-05-04

6.  Metastatic follicular thyroid cancer in a patient with Birt-Hogg-Dubé syndrome.

Authors:  Elisa K Bongetti; Rajesh Raj; Duncan R Cooke; Mathew C Mathew
Journal:  Clin Case Rep       Date:  2020-11-06

7.  Blockade of β2-Adrenergic Receptor Reduces Inflammation and Oxidative Stress in Clear Cell Renal Cell Carcinoma.

Authors:  Virginia Albiñana; Lucía Recio-Poveda; Pilar González-Peramato; Luis Martinez-Piñeiro; Luisa María Botella; Angel M Cuesta
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

8.  The genomic landscape of pediatric renal cell carcinomas.

Authors:  Pengbo Beck; Barbara Selle; Lukas Madenach; David T W Jones; Christian Vokuhl; Apurva Gopisetty; Arash Nabbi; Ines B Brecht; Martin Ebinger; Jenny Wegert; Norbert Graf; Manfred Gessler; Stefan M Pfister; Natalie Jäger
Journal:  iScience       Date:  2022-03-26

Review 9.  Clear cell renal cell carcinoma ontogeny and mechanisms of lethality.

Authors:  Eric Jonasch; Cheryl Lyn Walker; W Kimryn Rathmell
Journal:  Nat Rev Nephrol       Date:  2020-11-03       Impact factor: 28.314

10.  Renal cell carcinoma histological subtype distribution differs by age, gender, and tumor size in coastal Chinese patients.

Authors:  Junlong Wu; Peipei Zhang; Guiming Zhang; Hongkai Wang; Weijie Gu; Bo Dai; Hailiang Zhang; Guohai Shi; Yijun Shen; Yiping Zhu; Yao Zhu; Dingwei Ye
Journal:  Oncotarget       Date:  2017-05-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.